Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy

被引：0
|
作者：
Daofu Feng
Meiha Leong
Ting Li
Lin Chen
Tao Li
机构：
[1] General Hospital of Chinese PLA,Department of General Surgery
[2] General Hospital of Tianjin Medical University,Department of General Surgery
[3] Kiang Wu Hospital,Department of Surgery
来源：
World Journal of Surgical Oncology | / 13卷
关键词：
Gastric cancer; D2 lymphadenectomy; Pathological complete response; Complications; Neoadjuvant chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Phase 2 study of neoadjuvant durvalumab plus docetaxel, oxaliplatin, and S-1 with surgery and adjuvant durvalumab plus S-1 for resectable locally advanced gastric cancer
    Kang, Yoon-Koo
    Kim, Hyung-Don
    Cho, Hyungwoo
    Park, Young Soo
    Lee, Jong Seok
    Ryu, Min-Hee
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (03)
  • [32] Neoadjuvant PD-1 inhibitor and apatinib combined with S-1 plus oxaliplatin for locally advanced gastric cancer patients: a multicentered, prospective, cohort study
    Xu, Chao
    Xie, Xiaoli
    Kang, Ning
    Jiang, Huiqing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 4091 - 4099
  • [33] Clinical benefits of combined chemotherapy with S-1, oxaliplatin, and docetaxel in advanced gastric cancer patients with palliative surgery
    Liu, Yan
    Feng, Ye
    Gao, Yongjian
    Hou, Ruizhi
    ONCOTARGETS AND THERAPY, 2016, 9 : 1269 - 1273
  • [34] A phase I study of docetaxel/oxaliplatin/S-1 (DOS) combination neoadjuvant chemotherapy for patients with locally advanced adenocarcinoma of the esophagogastric junction
    Kei Hosoda
    Mizutomo Azuma
    Chikatoshi Katada
    Kenji Ishido
    Masahiro Niihara
    Hideki Ushiku
    Mikiko Sakuraya
    Marie Washio
    Takuya Wada
    Akinori Watanabe
    Hiroki Harada
    Satoshi Tanabe
    Wasaburo Koizumi
    Keishi Yamashita
    Naoki Hiki
    International Journal of Clinical Oncology, 2020, 25 : 1090 - 1097
  • [35] Survival outcomes of locally advanced gastric cancer cases with pathological complete response received neoadjuvant chemotherapy
    Hu, Qing
    Wang, Jian
    Xu, Wei-Guo
    Shao, Peng
    Li, Gang
    PRECISION MEDICAL SCIENCES, 2021, 10 (02): : 78 - 82
  • [36] Neoadjuvant Intraperitoneal and Systemic Chemotherapy Versus Neoadjuvant Systemic Chemotherapy With Docetaxel, Oxaliplatin, and S-1 for Gastric Cancer With Peritoneal Metastasis: A Propensity Score Matched Analysis
    Zhang, Xin
    Huang, Hejing
    Yang, Dejun
    Wang, Peng
    Huang, Xin
    Hu, Zunqi
    Zhang, Yu
    Yan, Ronglin
    Zhu, Zhenxin
    Cai, Qingping
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [37] The validity of neoadjuvant chemotherapy with paclitaxel plus S-1 is not inferior to that of SOX regimen for locally advanced gastric cancer: an observational study
    Zhang, Chenghai
    Wu, Binghong
    Yang, Hong
    Yao, Zhendan
    Zhang, Nan
    Tan, Fei
    Liu, Maoxing
    Xu, Kai
    Chen, Lei
    Xing, Jiadi
    Cui, Ming
    Su, Xiangqian
    BMC CANCER, 2022, 22 (01)
  • [38] Phase II clinical trial to study the safety and efficacy of combined S-1+oxaliplatin therapy as neoadjuvant chemotherapy for locally advanced gastric cancer in older patients
    Ota, Mitsuhiko
    Saeki, Hiroshi
    Uehara, Hideo
    Matsuda, Yoshiko
    Tsutsumi, Satoshi
    Kusumoto, Tetsuya
    Yasui, Hisateru
    Ubukata, Yasunari
    Yamaguchi, Shohei
    Orita, Hiroyuki
    Izawa, Naoki
    Kakizoe, Saburo
    Shimokawa, Mototsugu
    Yoshizumi, Tomoharu
    Kakeji, Yoshihiro
    Mori, Masaki
    Oki, Eiji
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (09) : 1166 - 1175
  • [39] The validity of neoadjuvant chemotherapy with paclitaxel plus S-1 is not inferior to that of SOX regimen for locally advanced gastric cancer: an observational study
    Chenghai Zhang
    Binghong Wu
    Hong Yang
    Zhendan Yao
    Nan Zhang
    Fei Tan
    Maoxing Liu
    Kai Xu
    Lei Chen
    Jiadi Xing
    Ming Cui
    Xiangqian Su
    BMC Cancer, 22
  • [40] Neoadjuvant chemotherapy for locally advanced gastric cancer: the surgeon's role
    Spampatti, Sebastiano
    Rausei, Stefano
    Galli, Federica
    Ruspi, Laura
    Peverelli, Chiara
    Frattini, Francesco
    Rovera, Francesca
    Boni, Luigi
    Dionigi, Gianlorenzo
    TRANSLATIONAL GASTROINTESTINAL CANCER, 2015, 4 (02) : 141 - 147
12345